Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

The pediatric neurologist at Duke Health and chief executive officer at Theranica talked about a remote electrical neuromodulation wearable that showed promising results for the treatment and prevention of migraine in pediatric patients. [WATCH TIME: 5 minutes]

Advancing the Treatment of Pediatric Migraine With Nerivio REN Wearable: Klaus Werner, MD & Alon Ironi

Articles

AL002 did not meet the primary endpoint of slowing Alzheimer's clinical progression, as measured by the Clinical Dementia Rating Sum of Boxes and showed no treatment effects on secondary clinical and functional endpoints.

AL002 Falls Short in Phase 2 INVOKE-2 Trial of Early Alzheimer Disease

The cofounder and chief science officer of the Alzheimer's Drug Discovery Foundation highlighted the critical role of collaboration and innovative diagnostics for advancing Alzheimer disease care. [WATCH TIME: 4 minutes]

Collaboration and Innovation in Alzheimer Disease Clinical Trial Research: Howard Fillit, MD

Over 1 year of treatment, simufilam failed to distinguish itself from placebo on the primary end points of Alzheimer’s Disease Assessment Scale-Cognitive Subscale 12 and Alzheimer’s Disease Cooperative Study-Activities of Daily Living.

Alzheimer Agent Simufilam Fails to Meet Primary End Point in Phase 3 Study

Here's the latest multidisciplinary multiple sclerosis (MS) research from the International Journal of MS Care.

Research from IJMSC October 2024

The neurologist in the Headache Center at Cleveland Clinic shared her post perspective on the 2024 AHS Scottsdale meeting which highlighted advancements in headache medicine and the growing impact of the field on patient care. [WATCH TIME: 5 minutes]

Highlights on Exploring Advances in Headache Medicine from AHS Scottsdale 2024: MaryAnn Mays, MD

The epilepsy specialist and Cleveland Clinic’s Chief Research and Information Officer discussed the wide-spread applicability of scalp EEG and the potential for machine learning models to help predict epilepsy surgery outcomes. [WATCH TIME: 4 minutes]

Scalability of Scalp EEG as a Tool for Epilepsy Surgery Outcomes: Lara Jehi, MD, MHCDS

Dean and chief academic officer at the University of Miami Miller School of Medicine.

The dean and chief academic officer at the University of Miami Miller School of Medicine discussed the university’s investment in computational biology to advance aging and neuroscience research. [WATCH TIME: 5 minutes]

Driving Innovation in Aging and Neurodegenerative Research: Henri Ford, MD, MHA 

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AANEM 2024

CTAD 2024

MDS 2024

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

Events

Franchise

Discussion Topic

Program Category

Registration Goal

NeurologyLive, Clinical Forum | NMOSD | Copenhagen, Denmark | 9.20.24

Rotunden - Nimb Hotel

2nd Annual Giants of Multiple Sclerosis Awards Program

Gaylord Rockies Resort & Convention Center, Adams Ballroom

NeurologyLive, Clinical Forum | NMOSD | NYC | 12.04.24

Redeye Grill

NeurologyLive, Clinical Forum | MS | Pittsburgh | 12.04.24 |

The Capital Grille

NeurologyLive, Clinical Forum | MS | NYC | 12.16.24

David Burke Tavern

NeurologyLive, Clinical Forum | NMOSD | Atlanta | 12.19.24

Davio’s Northern Italian Steakhouse

KOL or Featured Speaker

4th Women in Neurology Conference

Cheyenne Mountain Resort

Events

Optimizing Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Utilization of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis

Utilization of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis

Optimizing Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD)

4th Annual Women in Neurology Conference

NeurologyLive® Clinical Forum: Optimizing Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD)

2nd Annual Giants of Multiple Sclerosis Awards Ceremony